{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:15:41Z","timestamp":1785604541029,"version":"3.56.0"},"reference-count":24,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T00:00:00Z","timestamp":1495411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003789","name":"Helwan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Basic Microbiol"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec><jats:label\/><jats:p>The fast progression of nanotechnology has led to novel therapeutic interventions. Antimicrobial activities of silver nanoparticles (Ag NPs) were tested against standard ATCC strains of <jats:italic>Staphylococcus aureus<\/jats:italic> (ATCC 9144), <jats:italic>Escherichia coli<\/jats:italic> (O157:H7), <jats:italic>Pseudomonas aeruginosa<\/jats:italic> (ATCC 27853), and <jats:italic>Candida albicans<\/jats:italic> (ATCC 90028) in addition to 60 clinical isolates collected from cancer patients. Antimicrobial activity was tested by disk diffusion method and MIC values for Ag NPs alone and in combination with N\u2010acetylcysteine (NAC) against tested pathogens were determined by broth microdilution method. Ag NPs showed a robust antimicrobial activity against all tested pathogens and NAC substantially enhanced the antimicrobial activity of Ag NPs against all tested pathogens. Synergism between Ag NPs and NAC has been confirmed by checkerboard assay. The effect of Ag NPs on tested pathogens was further scrutinized by Transmission Electron Microscope (TEM) which showed disruption of cell wall in both bacteria and fungi. Ag NPs abrogated the activity of respiratory chain dehydrogenase of all tested pathogens and released muramic acid content from <jats:italic>S. aureus<\/jats:italic> in culture. The cytotoxic effect of Ag NPs alone and in combination with NAC was examined using human HepG2 cells and this revealed no cytotoxicity at MIC values of Ag NPs and interestingly, NAC reduced the cytotoxic effect of Ag NPs at concentrations higher than their MIC values. Taken together, Ag NPs have robust antimicrobial activity and NAC substantially enhances their antimicrobial activities against MDR pathogens which would provide a novel safe, effective, and inexpensive therapeutic approach to control the prevalence of MDR pathogens.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jobm.201700087","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T23:10:41Z","timestamp":1495581041000},"page":"659-668","source":"Crossref","is-referenced-by-count":46,"title":["Silver nanoparticles: Antimicrobial activity, cytotoxicity, and synergism with N\u2010acetyl cysteine"],"prefix":"10.1002","volume":"57","author":[{"given":"Selwan","family":"Hamed","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Department of Microbiology and Immunology Helwan University Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7708-9435","authenticated-orcid":false,"given":"Mohamed","family":"Emara","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Department of Microbiology and Immunology Helwan University Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham M.","family":"Shawky","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Department of Microbiology and Immunology Helwan University Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramadan A.","family":"El\u2010domany","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Department of Microbiology and immunology Kafr El Sheikh University Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq","family":"Youssef","sequence":"additional","affiliation":[{"name":"National Institute of Laser Enhanced Sciences Cairo University Giza Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,22]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2011.07.002"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2009.08.001"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1086\/595011"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60847-7"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d3737"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jobm.201500268"},{"key":"e_1_2_7_8_1","first-page":"2767","article-title":"Antimicrobial applications of nanotechnology: methods and literature","volume":"7","author":"Seil JT","year":"2012","journal-title":"Int J Nanomed"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-3155-9-30"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules16108894"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2012.0155"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-014-0782-9"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2014.01.071"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.09.007"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2014.12.084"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2007.10.004"},{"key":"e_1_2_7_17_1","first-page":"2399","article-title":"Nanosilver particles in medical applications: synthesis, performance, and toxicity","volume":"9","author":"Ge L","year":"2014","journal-title":"Int J Nanomed"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2010.10.008"},{"key":"e_1_2_7_19_1","unstructured":"CLSI. Zone diameter Interpretive Standards and corresponding minimal inhibitory concentration interpretive break point. Clinical and Laboratory Standard Institute 2012. Supplement M44\u2010S1."},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg301"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7012(01)00249-4"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00710-10"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2009.08.025"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.12691\/ajeid-3-1-1"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmic.2011.04.009"}],"container-title":["Journal of Basic Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjobm.201700087","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jobm.201700087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T13:00:36Z","timestamp":1696510836000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jobm.201700087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,22]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1002\/jobm.201700087"],"URL":"https:\/\/doi.org\/10.1002\/jobm.201700087","archive":["Portico"],"relation":{},"ISSN":["0233-111X","1521-4028"],"issn-type":[{"value":"0233-111X","type":"print"},{"value":"1521-4028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,22]]}}}